by admin_prosemble | 30th January 2026 | News
Prosemble has received results from ongoing test of its protein nanoparticles in CD34+ humanised NCG mice. The results indicate excellent immunogenicity, with no B-cell activation, minimal cytokine production, and T-cell activation only due to natural ageing. Next...
by admin_prosemble | 22nd January 2026 | News
On 22 January 2026, Inna Zhuranskaya participated in the Women-Led Global Business Programme in Health-Tech, organized by the Biotechnology Industry Research Assistance Council (BIRAC) in collaboration with UKRI India and Innovate UK. The delegation’s visit to Chennai...
by admin_prosemble | 21st January 2026 | News
On 21 January 2026, Inna Zhuranskaya participated in the UK Research and Innovation (UKRI) & Innovate UK Global Business Innovation Programme (GBIP) – Women in Innovation Health-Tech, hosted in Bengaluru. The delegation, featuring 12 women-led companies from the...
by admin_prosemble | 20th January 2026 | News
On 19 January 2026, Inna Zhuranskaya participated in the UK Women-Led Startup Cohort event hosted by UKRI India, alongside Innovate UK and IKP Knowledge Park. During the event, she shared valuable insights on navigating healthcare systems across borders, a critical...
by admin_prosemble | 19th January 2026 | News
Inna Zhuranskaya and Prosemble would like to extend their heartfelt thanks to Dilruk Yahathugoda for his invaluable support during the Innovate UK Global Business Innovation Programme (GBIP) – Healthcare Women in Innovation in Bengaluru. This initiative has provided a...
